Oxford Nanopore Technologies plc (ONTTF)
USD 1.61
(8.78%)
USD 1.61
(8.78%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 41.65 Million GBP | 22.16% |
| 2022 | 34.09 Million GBP | 37.47% |
| 2021 | 24.8 Million GBP | 4.96% |
| 2020 | 23.63 Million GBP | 23.85% |
| 2019 | 19.08 Million GBP | 100.85% |
| 2018 | 9.5 Million GBP | 0.0% |
| 2017 | 9.5 Million GBP | 0.0% |
| 2016 | - GBP | 0.0% |
| 2015 | - GBP | 0.0% |
| 2014 | - GBP | 0.0% |
| 2013 | - GBP | 0.0% |
| 2012 | - GBP | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 46.7 Million GBP | 0.0% |
| 2023 Q4 | 41.65 Million GBP | 11.58% |
| 2023 FY | 41.65 Million GBP | 22.16% |
| 2023 Q1 | 17.9 Million GBP | -47.5% |
| 2023 Q2 | 32.62 Million GBP | 82.26% |
| 2023 Q3 | 37.33 Million GBP | 14.43% |
| 2022 Q4 | 34.09 Million GBP | 13.5% |
| 2022 FY | 34.09 Million GBP | 37.47% |
| 2022 Q3 | 30.04 Million GBP | 25.4% |
| 2022 Q2 | 23.95 Million GBP | 21.4% |
| 2022 Q1 | 19.73 Million GBP | -20.44% |
| 2021 Q4 | 24.8 Million GBP | 11.76% |
| 2021 FY | 24.8 Million GBP | 4.96% |
| 2021 Q1 | 21.49 Million GBP | -9.03% |
| 2021 Q2 | 23.28 Million GBP | 8.31% |
| 2021 Q3 | 22.19 Million GBP | -4.68% |
| 2020 Q4 | 23.63 Million GBP | 9.44% |
| 2020 FY | 23.63 Million GBP | 23.85% |
| 2020 Q3 | 21.59 Million GBP | 0.0% |
| 2020 Q1 | - GBP | 0.0% |
| 2019 FY | 19.08 Million GBP | 100.85% |
| 2018 FY | 9.5 Million GBP | 0.0% |
| 2017 FY | 9.5 Million GBP | 0.0% |
| 2016 FY | - GBP | 0.0% |
| 2015 FY | - GBP | 0.0% |
| 2014 FY | - GBP | 0.0% |
| 2013 FY | - GBP | 0.0% |
| 2012 FY | - GBP | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Capstone Therapeutics Corp. | 20.32 Million USD | -104.914% |
| Skye Bioscience, Inc. | 4.61 Million USD | -802.548% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -39.936% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -33904.082% |
| Qrons Inc. | 351.84 Thousand USD | -11738.953% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -609.493% |
| BioStem Technologies, Inc. | 4.71 Million USD | -784.129% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -5408.434% |
| CSL Limited | 12.18 Billion USD | 99.658% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 8.571% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 3.961% |
| Rebus Holdings, Inc. | 310 Thousand USD | -13337.097% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -6511.097% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -161861.974% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -1.097% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -910.564% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -10265.834% |
| SQZ Biotechnologies Company | 27.47 Million USD | -51.633% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -1690.877% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -4292.732% |
| Mesoblast Limited | 118.7 Million USD | 64.907% |
| Marizyme, Inc. | 18.71 Million USD | -122.546% |
| Genus plc | 233.1 Million USD | 82.13% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -1321.484% |
| Pharming Group N.V. | 171.54 Million USD | 75.718% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -4590.54% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -3000.29% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -5454.0% |
| ContraFect Corporation | 2.88 Million USD | -1345.852% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -30644.647% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -2780.07% |
| IMV Inc. | 28.88 Million USD | -44.215% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -636.168% |
| MultiCell Technologies, Inc. | 202.58 USD | -20562147.014% |
| ONE Bio Corp. | 19.71 Million USD | -111.286% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 27.543% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -2686.752% |
| Q BioMed Inc. | 4.1 Million USD | -913.508% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -25.842% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -3291.104% |
| Biomind Labs Inc. | 735.54 Thousand USD | -5563.171% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 38.419% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -1276.483% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -220.497% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -11480.162% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -29334.418% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -1744.463% |
| GB Sciences, Inc. | 1.75 Million USD | -2267.694% |
| Alpha Cognition Inc. | 1.22 Million USD | -3313.303% |
| HST Global, Inc. | 98.31 Thousand USD | -42267.193% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -16647.748% |
| Halberd Corporation | 150 Thousand USD | -27670.0% |
| Enzolytics Inc. | 996.33 Thousand USD | -4080.81% |
| Agentix Corp. | 50 Thousand USD | -83210.0% |
| Resverlogix Corp. | 6.49 Million USD | -541.735% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -16197.458% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | -108.275% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -488.946% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -1437.821% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -407283.863% |
| Genscript Biotech Corporation | 417.73 Million USD | 90.028% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -20663.548% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -1637.273% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -18066.871% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -27921.446% |
| Kadimastem Ltd | 891.22 Thousand USD | -4573.899% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -16549.879% |
| LadRx Corporation | 33.6 Thousand USD | -123851.08% |
| Cell Source, Inc. | 9.25 Million USD | -350.121% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -5408.434% |
| NovAccess Global Inc. | 2.19 Million USD | -1793.512% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -18139.578% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -19644.046% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -735.942% |
| Mobile Lads Corp. | 484.28 Thousand USD | -8501.358% |
| CytoDyn Inc. | 30.07 Million USD | -38.499% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -432.675% |
| SYBLEU INC | 477.5 Thousand USD | -8623.56% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -779.673% |
| International Stem Cell Corporation | 4.17 Million USD | -897.008% |
| Bioxytran, Inc. | 1.92 Million USD | -2063.896% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -66640.903% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -1809.991% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -400.902% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -385.207% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -2577.953% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -15442.91% |
| Neutra Corp. | 54.15 Thousand USD | -76816.685% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -2176.23% |
| PureTech Health plc | 25.51 Million USD | -63.276% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -3302.558% |
| IXICO plc | 472.02 Thousand USD | -8724.782% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -168.725% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 33.098% |
| CSL Limited | 12.18 Billion USD | 99.658% |
| Cellectis S.A. | 92.77 Million USD | 55.102% |